B J Madan, A Family Owned Enterprise, had its inception in the year 1956. Our mainstay in the Pharmaceutical & Healthcare Industry stretches over 7 decades. In the year 2005, as the 3rd generation of the family, I inherited this family business, and forayed in the field of Nuclear Medicine In India, with strong fundamental in Pharmaceuticals. Our Journey in Nuclear Medicine started with the pioneers in the domains of PET precursors, F18 Chemistry & Peptides, thereby graduating into the field of Theranostics, synergising with the objectives of the Precision Oncology, We are proud to represent in India, our principal companies from across the world, a journey we started 15 years ago and our relationships still going strong. We have successfully integrated the global innovations of our principal companies into the brilliance, dynamism and clinical efficiency of the nuclear medicine fraternity of India. We stay dedicated to our vision and objective, of Targeting Tumors. Representing In India: ABX-Germany. ITG-Germany. Oncobeta- Germany.CMR-Russia. GMS-USA. Cellbion-Korea. ORA-Belgium.Lablogic- United Kingdom